Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 10 of 10 entries
View as:

A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons

Phase: N/A Priority: Normal
NCT ID: NCT00002130 Org: User:
Start: - End: - Due: -

POCone-UBiT-IR300 Pediatric Comparison Study

Phase: N/A Priority: Normal
NCT ID: NCT01623154 Org: User:
Start: 07/31/12 End: 04/30/13 Due: 04/30/14

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00002131 Org: User:
Start: - End: - Due: -

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Phase: N/A Priority: Normal
NCT ID: NCT00048776 Org: User:
Start: 10/31/01 End: 06/30/03 Due: 06/30/04

Study for the Treatment of Crohn's Disease With Adacolumn

Phase: N/A Priority: Normal
NCT ID: NCT00162942 Org: User:
Start: 01/31/05 End: 12/31/07 Due: 12/31/08

Study for the Treatment of Ulcerative Colitis With Adacolumn

Phase: N/A Priority: Normal
NCT ID: NCT00102193 Org: User:
Start: 07/31/04 End: 07/31/06 Due: 07/31/07

A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease

Phase: N/A Priority: Normal
NCT ID: NCT00002337 Org: User:
Start: - End: - Due: -

A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00002129 Org: User:
Start: - End: - Due: -

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT01240668 Org: User:
Start: 09/30/10 End: 08/31/13 Due: 08/31/14

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Phase: N/A Priority: Normal
NCT ID: NCT00048763 Org: User:
Start: 10/31/01 End: 06/30/03 Due: 06/30/04